ZKY001 simulated eye drops
Sponsors
Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.
Conditions
Corneal DefectCorneal Epithelial Defect
Phase 2
Evaluating the Efficacy and Safety of ZKY001 Eye Drops in the Treatment of Corneal Epithelial Defects
NCT04228926
Start: 2020-12-24End: 2021-12-31Target: 105Updated: 2021-09-17
ZKY001 Eye Drops in the Treatment of Corneal Epithelial Defects in a Phase Ⅱ Clinical Trial
CompletedNCT06213727
Start: 2022-03-15End: 2022-11-14Updated: 2024-01-19